Biogen | BIIB - 股票



金融业
股票价格
USD
资产
USD 32.09B
现金及等价物
USD 1.29B
销售成本
USD 945.1M
流动资产
USD 7.31B
流动负债
USD 3.92B
债务
USD 8.09B
EBIT
USD -243.8M
EBITDA
USD 649.7M
员工
7.61K
EPS每股收益
USD 3.6
股本和储备
USD 18.85B
销售毛利
USD 2.12B
债务利息支出
USD 72.6M
利息收入
USD 37.9M
贷款资金
USD 7.29B
市值
USD 31.89B
净收入
USD 97.5M
营业费用
USD 2.98B
营业利润
USD -243.8M
普通股股本
USD 146.7M
PE价格收益
23.23
税前利润
USD 647.3M
销售收入
USD 2.74B
销售和管理费用
USD 709.7M
股票
USD 2.38B
贸易债权人
USD 403.9M
应收帐款人
USD 1.79B


股票 更改 日
AbbVie USD 5.13B 78M 2026-06
Acadia Pharmaceuticals USD 108.67M 77.1M 2026-06
ALKERMES USD 298.96M 37.75M 2026-06
Amgen USD 6.22B 34M 2026-06
Bayer EUR 11.97B 43M 2026-06
Biogen USD 2.38B 435.3M 2026-06
BioMarin Pharmaceutical USD 1.78B 509.3M 2026-06
Bristol-Myers Squibb USD 2.74B 19M 2026-06
Eli Lilly USD 16.79B 2.26B 2026-06
Gilead Sciences USD 1.91B 140M 2026-03
Incyte USD 112.54M 3.08M 2026-06
Merck USD 6.21B 272M 2026-06
Moderna USD 280M 134M 2026-06
Neurocrine Biosciences USD 104.2M 39.7M 2026-06
Novartis USD 6.22B 66M 2026-06
Pfizer USD 9.94B 722M 2026-06
PTC Therapeutics USD 91.35M 15.79M 2026-06
Puma Biotechnology USD 9.48M 885K 2025-09
Regeneron Pharmaceuticals USD 3.08B 19.3M 2026-06
Sanofi EUR 24.12B 620M 2026-06
Sanofi EUR 23.5B 812M 2026-03
Sarepta Therapeutics USD 904.27M 96.84M 2026-06
Teva Pharmaceutical Industries USD 3.18B 3M 2026-03
Ultragenyx Pharmaceutical USD 59M 4M 2026-06
United Therapeutics USD 193.8M 15.5M 2026-06
Vertex Pharmaceuticals USD 1.77B 1.6M 2026-06